The global demand for Medical Polycarbonate Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Polycarbonate (PC) is one of the fastest growing plastics in the medical field, mainly due to a favorable combination of cost and performance factors. Usual properties of PC that give them an advantage in the healthcare industry contain great strength, toughness, rigidity and resistance to rigorous sterilization conditions. The high clarity of PC is also anadvantage in many medical applications.
PC is not the most widely used plastic in medical products. That distinction belongs to PVC, PE, PP and polystyrene. However, engineering thermoplastics such as PC offers levels of heat and radiation resistance that PVC and other commonly used medical plastics cannot match. The strength and chemical inertness of PC makes it useful for tools used in minimally invasive surgery, a field that is expanding rapidly. PC also costs less than other high-performance engineering plastics used in medicine, such as polysulfone and polyetheretherketone.
Market Dynamics
The growth of this market is mainly driven by advantages of polycarbonate such as higher resistance to chipping, higher durability, withstand different sterilization and provides higher performance. Growing prevalence of the chronic medical issues such as heart diseases, renal diseases and others driving the need for surgeries. Rise in surgical procedures worldwide is creating higher need for medical and surgical devices, drives the demand for medical polycarbonate. Increase in home healthcare resulting into higher demand for self-monitoring medical equipment is also demanding the need for polycarbonate for medical application.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of medical polycarbonate.
Market Segmentation
The entire medical polycarbonate market has been sub-categorized into grade, processing technology and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Grade
- Lipid-resistant Grade
- High-temperature Grade
By Processing Technology
- Extrusion
- Injection Molding
- Blow Molding
- Others (Product 4, Product 5, Product 6)
By Application
- Fluid Delivery & IV Connection Components
- Renal Dialysis Products
- Cardiovascular Devices
- Surgical Instruments
- Others
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for medical polycarbonate market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Medical Polycarbonate Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the medical polycarbonate market include Covestro AG, Mitsubishi Engineering-Plastics Corporations, SABIC, Trinseo S.A., Lotte Chemical Corporation, GOEX Corporation, Chi Mei Corp and others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.